首页 | 本学科首页   官方微博 | 高级检索  
     

尿激酶静脉溶栓治疗急性心肌梗死68例疗效观察
引用本文:许勤华. 尿激酶静脉溶栓治疗急性心肌梗死68例疗效观察[J]. 河南医药信息, 2010, 0(20): 72-73,77
作者姓名:许勤华
作者单位:河南省南阳市中心医院急救中心,南阳市473009
摘    要:目的观察尿激酶(UK)静脉溶栓治疗急性心肌梗死的疗效。方法选择急诊急性心肌梗死患者132例,随机分为治疗组68例和对照组64例,治疗组给尿激酶溶栓治疗,而对照组给予常规治疗。用药后观察两组患者血管再通情况和病死率以及并发症发生情况。结果治疗组总的血管再通率高于对照组(P〈0.01);治疗4周后,对照组的病死率、急性肺水肿和心源性休克发生率高于治疗组(P〈0.01)。结论尿激酶静脉溶栓疗效可靠、安全、使用方便、不良反应发生率低且轻微,适合基层医院对AMI的抢救。

关 键 词:急性心肌梗死  静脉溶栓  急诊  疗效

Intravenous Thrombolytic Therapy in Acute Myocardial Infarction 68 Cases
XU Qinhua. Intravenous Thrombolytic Therapy in Acute Myocardial Infarction 68 Cases[J]. Henan Medical Information, 2010, 0(20): 72-73,77
Authors:XU Qinhua
Affiliation:XU Qinhua Nanyang City Center Hospital, Nanyang 473000, China
Abstract:Objective To observe the urokinase(UK) thrombolytic therapy in acute myo-cardial infarction.Methods Patients with acute myocardial infarction 132 cases,were randomly di-vided into treatment group 68 cases and control group 64 cases,the treatment group was given intrave-nous thrombolytic therapy and the control group received conventional therapy.Patients were observed after administration of vascular recanalization and mortality and complications.Results The total re-vascularization rate was higher(P 〈0.01);4 weeks after treatment,the mortality in control group,a-cute pulmonary edema and cardiogenic shock was higher than in the treatment group(P 〈 0.01).Conclusion The efficacy of intravenous thrombolysis with urokinase is reliable,safe,convenient,and low incidence of minor side effects,suitable for the primary hospital AMI rescue
Keywords:Acute myocardial infarction  Intravenous thrombolysis  Emergency  Effect
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号